Fundamentals of Liver Disease - Abnormal Liver Tests 2.0

4.83 (12 votes)

DESCRIPTION
Currently, there is an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.

The overall goal is to improve patient care by increasing learner competence and confidence in both proper patient identification and assessment and increasing learner performance in therapeutic options and on-treatment management strategies for patients. Patient outcomes will be improved as a result of the improvements in more providers understanding these key components in the management and care of patients with liver diseases.

KEY TOPIC AREAS
Anatomy and Physiology of the Liver
Liver Tests
Acute Hepatocellular Injury
Acute Cholestatic Liver Injury
Chronic Hepatocellular Injury
Chronic Cholestatic Injury
Interpretation of Viral Serologies in Acute and Chronic Hepatitis
Outcomes of Patients with Abnormal Liver Tests

Release date: November 5, 2019
Expiration date: November 4, 2022
Time to complete each module: 30 minutes

CREDITS OFFERED

Continuing Medical Education (CME): For a maximum of 4.00 AMA PRA Category 1 Credits™ 
Continuing Education (CE): For a maximum of 4.00 Contact Hour
You may only earn one Continuing Education Credit type- either CE or CME

Maintenance of Certification (MOC): For a maximum of 4.00 MOC Points

COMPONENTS
Online presentations comprised of PowerPoint slides and accompanying audio, online pre- and post-tests and evaluations:
-8 online, narrated modules 25 to 30 minutes in length
-Pre- and post-test questions for each module
-Evaluation for CE or CME credit offering (only complete 1 evaluation for the type of credits you are earning)

DIRECTIONS
Click "Activate" to register for the enduring material. Review all section tabs before you begin. Select module of interest. Complete necessary components to claim either CE or CME, and MOC.

COPYRIGHT
All faculty in this activity have given their permission for publication ©2019 AASLD. 

CONTACT INFORMATION
For questions on CME and  MOC content or LiverLearning®, contact online_education@aasld.org
For questions on CE credit for this enduring material, contact Certificate@AmedcoEmail.com

LEARNING OBJECTIVES

· Discuss normal liver function and anatomy.
· Identify routine liver tests, when to order and how to interpret results.
· Recognize acute hepatocellular injury and cholestatic injury based on liver tests results.
· Recognize chronic hepatocellular injury and chronic cholestatic injury based on liver tests results.
· Describe outcomes for patients with abnormal liver tests.

This enduring material was developed for the following:

  • Hepatologists
  • Gastroenterologists
  • Nurses
  • Nurse Practitioners
  • Pharmacists
  • Physician Assistants
  • Transplant Coordinators
  • Surgeons
  • Fellows/Trainees
  • Primary Care Physicians
  • Other healthcare providers

CREDITS OFFERED
Continuing Medical Education (CME): For a maximum of 4.00 AMA PRA Category 1 Credits™
Maintenance of Certification (MOC): For a maximum of 4.00 MOC Points
Continuing Education (CE): For a maximum of 4.00 Contact Hours

ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this enduring activity for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

image

Continuing Education (Nursing Contact Hours)  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the American Association for the Study of Liver Diseases.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this enduring material activity for a maximum of 4.00 contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CME CREDITS
Physicians and other health care professionals for a maximum of 4.00 AMA PRA Category 1 Credits™ for this enduring continuing medical education material must completed by November 4, 2022

CLAIMING ABIM MOC POINTS 
Physicians seeking ABIM MOC credit must complete the enduring material by November 4, 2022. Requests for MOC after this date will not be honored. MOC Points will be reported to the ABIM by the end of each month through December 2022 for individuals who successfully complete MOC.

CLAIMING CE CREDITS
Nurses for a maximum of 4.00 contact hours for this enduring continuing education material must be completed by November 4, 2022

HOW TO EARN AND CLAIM MOC POINTS
For each module that you wish to claim MOC points for you must:

             o    Complete the pre-test

             o    Watch video presentation

             o    Complete the post-test and pass with a score of 70% or higher (Participants have unlimited attempts to earn the passing score.)

             o    Claim CME credits (ABIM Rule: MOC points must be equivalent to the amount of CME credits claimed for the activity.)

MOC completions are collected on the 15th of each month and submitted to the ABIM by the last day of the month. Points are not submitted automatically and will not display immediately on your ABIM MOC Profile.

MOC points are available for ABIM board certified physicians only.

Tamar H. Taddei

Tamar Taddei, MD, FAASLD is an Associate Professor of Medicine in the Section of Digestive Diseases at Yale University and staff hepatologist at the VA Connecticut Healthcare System in West Haven, CT. She directs the liver cancer program at VA Connecticut.  She is Associate Director of the MD/PhD Program at Yale School of Medicine.  She is a board certified gastroenterologist with a certificate of added qualification in transplant hepatology.  Her clinical interests include end stage liver disease, liver transplantation, and liver cancer.  She leads the VA Connecticut’s Cancer Care Tracking System Team, a group that has facilitated early detection of cancer and timely access to comprehensive cancer care through innovation in systems of care and technology.  She is co-PI of the Veterans Outcomes and Costs Associated with Liver disease (VOCAL) Study Group.

Hugo E. Vargas

Hugo E. Vargas, MD, FAASLD is a Mayo Clinic Consultant in the Department of Gastroenterology and Hepatology and the Mayo Clinic Transplantation Center. He is the Medical Director for the Office of Clinical Research – Arizona, and a Professor of Medicine in the Mayo Clinic Alix School of Medicine. Dr. Vargas is the Chair of the Clinical Research Subcommittee, and the Vice Chair of the Arizona Research Operations Management Team.  

Dr. Vargas has authored or coauthored more than 125 peer-reviewed articles. He is a Fellow of the AASLD, AGA, ACG, ASGE and ACP. He has been active in AASLD and has chaired the Annual Meeting Education Committee, Ethics Commiteee and co-chaired the AASLD/IDSA HCV group from 2016 to 2018. 

Oren K. Fix

Oren K. Fix, MD, MSc, FAASLD is Medical Director of the Liver Transplant Program at Swedish Medical Center in Seattle. He earned his medical degree at SUNY Buffalo School of Medicine and a masters degree in Epidemiology from Boston University School of Public Health. He completed his Internal Medicine residency and Gastroenterology fellowship at Boston University and Transplant Hepatology fellowship at University of California San Francisco (UCSF). Dr. Fix was a site principal investigator in the NIH-funded Acute Liver Failure Study Group for 8 years at University of Washington and UCSF. He has published over 45 peer-reviewed manuscripts and book chapters, many on the topic of acute liver failure.

Victor J. Navarro

Victor J. Navarro, MD, MHCM, FAASLD earned his Doctor of Medicine degree from the Pennsylvania State College of Medicine and completed medical residency followed by chief residency in Internal Medicine at Temple University.  Thereafter, he obtained fellowship training in Gastroenterology, Hepatology, and Hepatobiliary Endoscopy at Yale University.  In 1994, Dr. Navarro joined the faculty of the Yale University School of Medicine as an Assistant Professor of Medicine and Epidemiology and the Director of its Liver Failure and Transplantation service. He was also the Director of the State of Connecticut Emerging Infections Program Liver Study Unit.  His scholarly work while at Yale focused on the population-based epidemiology of chronic liver disease. In 2019, Dr. Navarro earned his Masters in Healthcare Management from Harvard University.

As a mentor, Dr. Navarro has been directly responsible for the scholarly and clinical training of many young and mid-career health professionals and academicians.  Dr. Navarro’s chief sources of research funding are the National Institutes of Health as an investigator for the U.S. Drug Induced Liver Injury Network (DILIN), and the Patient Centered Outcomes Research Institute for his study of Palliative Care in Patients with End Stage Liver Disease.

Manal F. Abdelmalek

Manal F. Abdelmalek, MD, MPH is tenured Professor of Medicine in the Division of Gastroenterology and Hepatology and Director of the NAFLD Clinical Research Program at Duke University. She received training in Internal Medicine, Gastroenterology and Hepatology at the Mayo Clinic, Scottsdale AZ and Rochester, MN and obtained a MPH degree with emphasis in epidemiology, public health and clinical investigation at the University of Florida, Gainesville, Florida.  Since first reporting on nonalcoholic fatty liver disease (NAFLD) as a cause of cryptogenic cirrhosis over 20 years ago, her clinical and research area of interest have been in the field of NAFLD, its associated risk factors for disease acquisition and progression and novel approaches to treatment. She has expertise in the design and conduct of clinical trials in NAFLD/ NASH including investigator-initiated, industry sponsored and NIH-funded clinical studies evaluating new therapies and biomarkers for NAFLD.  She collaborates extensively to translate new compounds to first-in-man clinical studies and the translation of clinic-to-bench and bench-to-clinic research to define pathogenic mechanisms underlying NAFLD acquisition and progression.  Dr. Abdelmalek is a Fellow of American College of Physicians, American College of Gastroenterology and American Association for the Study of Liver Disease.  She is a standing member of NASH Clinical Research Network (NASH CRN).  She has over 150 publications authored publications in the field of liver disease, the majority of which are in the area of NAFLD. 

Cynthia Levy

Cynthia Levy, MD, FAASLD is currently a Professor of Medicine in the Division of Hepatology at the University of Miami Miller School of Medicine. Dr. Levy received her MD from Universidade Federal do Rio de Janeiro, Brazil. She completed an Internal Medicine residency at University of Miami, a Gastroenterology Fellowship at Mayo Clinic, Rochester, and a Transplant Hepatology Fellowship at University of Florida, Gainesville, having received an AASLD Fellowship Award. Dr. Levy is a member of the AASLD Practice Guidelines Committee and of the ABIM Test and Policy Committee on Transplant Hepatology.  At the University of Miami, Dr. Levy is the program director for the Transplant Hepatology Fellowship program and Associate Director for the Schiff Center for Liver Diseases, where she conducts several industry-sponsored and investigator-initiated studies for cholestatic and autoimmune liver diseases.

Mindie H. Nguyen

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD is an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, School of Medicine, Stanford University in Palo Alto, California, USA. Her main fields of scientific and clinical interest are the epidemiology and management of chronic viral hepatitis, non-alcoholic fatty liver disease and liver cancer, with over 100 peer- reviewed scientific journal articles. She has served as a member of the Steering Committee for the Hepatobiliary Neoplasia Special Interest Group, HBV Special Interest Group, Education Committee and the Hepatology Associate Committee for the AASLD and as research mentor for over 100 trainees and faculty.

Meena B. Bansal

Meena B. Bansal, MD, FAASLD is currently Professor of Medicine in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President, Population Health for Quality and Efficiency. Dr. Bansal attended Harvard University and then Cornell Medical School. She did her internship and residency at Cornell Medical School and then completed Gastroenterology Fellowship at the University of Pennsylvania in 2001.

Her current research interests focus on the impact of HIV on hepatic inflammation and fibrosis. She became the Director of Translational Research in the Division of Liver Diseases in 2013 and has been principal investigator for numerous clinical trials ranging from HCV to NASH. In 2013, she became the Medical Director of all Hospital-based Clinics at Mount Sinai. In this latter role she developed an interest in population health and the challenges of the evolving health care landscape. Over the past 5 years, her focus has also been on building a population health infrastructure that will allow a large academic health system to be successful in value-based care.

DISCLOSURE OF CONFLICTS OF INTEREST
AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosures are collected prior to the start of the educational activity. Any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.

The enduring material organizers, faculty, reviewers and staff have reported the following disclosures:

Tamar H. Taddei, MD, FAASLD
Faculty
Grant/research support: Bayer Healthcare Pharmaceuticals 
Consulting: Onyx Pharmaceuticals

Hugo E. Vargas, MD, FAASLD
Faculty
Nothing to disclose

Oren K. Fix, MD, MSc, FAASLD
Faculty
Nothing to disclose

Victor J. Navarro, MD, MHCM, FAASLD
Faculty
Nothing to disclose

Manal F. Abdelmalek, MD, MPH
Faculty
Grant/research support: Gilead Sciences, TaiwanJ, NGM, Bristol-Myers Squibb, Genfit, Allergan, Madrigal, Conatus, Boehringer-Ingelhiem, Promethues, Galmed, Novartis, Enanta and Intercept Pharmaceuticals
Consulting:  TaiwanJ, Bristol-Myers Squibb, Siemens Heathineers, Prometic, and Inventiva

Cynthia Levy, MD, FAASLD
Faculty
Grant/research support: Gilead Sciences, Intercept, CymaBay, Novartis, GSK, Lilly, Enanta, Genkyotex, Genfit, Durect, HighTide, Alnylam
Consulting: Cara Therapeutics, Target PharmaSolutions, Pliant, GSK
Associate Editor: Liver Transplantation
Royalities up-to-date

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Faculty
Honoraria and research support: Janssen Pharmaceuticals, Gilead Sciences, Spring Bank, Intercept, Anylam, Pfizer and Novartis

Meena B. Bansal, MD, FAASLD
Faculty
Nothing to disclose

Sanjeeva Arora, MD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Lauren A. Beste, MD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Amanda J. Chaney, DNP, APRN, FNP-BC
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Royalities: Springer Publishing-Author

Guadalupe Garcia-Tsao, MD, FAASLD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Advisory Board: Intercept, Conatus
Scientific Consultant/Advisor to Industry or Commercial Enterprises, including Development of Education Presentations: Conatus, Galectin
Research Grants: Intercept

Leslie Hayes
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Minhhuyen Nguyen, MD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Vicki Shah, PA
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Scientific Consultant/Advisory to Industry or Commercial Enterprise, including Development of educational Presentations: Gilead, Intercept, AbbVie Advisory Board, Gilead Advisory Board

Raj Vuppalanchi, MD, FAASLD
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Data Safety Monitoring Board for Industry or Commercial Enterprise: Enanta, Covence

Susan Zapatka, MSN
Fundamentals of Liver Disease Committee/Organizer/Reviewer
Nothing to disclose

Dominique Clayton
AASLD Staff
Nothing to disclose

Janeil Klett
AASLD Staff
Nothing to disclose

Denise Seise
AASLD Staff
Nothing to disclose

Sheryl Morgan
Amedco LLC Staff
Nothing to disclose

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Acknowledgement of Commercial Support:
No commercial support was received for this enduring material activity.

Key:

Complete
Failed
Available
Locked
Acknowledgement of MOC Submission
Required for participants claiming ABIM MOC.
Required for participants claiming ABIM MOC.
Module 1: Anatomy and Physiology of the Liver
Module 1 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 1: Anatomy and Physiology of the Liver
Open to view video.
Open to view video.
Module 1 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 1 CE Evaluation (Complete Only If Claiming CE Credits)
12 Questions
Module 1 CE Credits (Complete Only If Claiming CE Credits)
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 1 CME Evaluation (Complete Only If Claiming CME Credits)
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 1 CME Credits (Complete Only If Claiming CME Credits)
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 1 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 2: Liver Tests
Module 2 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 2: Liver Tests
Open to view video.
Open to view video.
Module 2 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 2 CE Evaluation
12 Questions
Module 2 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 2 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 2 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 2 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 3: Acute Hepatocellular Injury
Module 3 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 3: Acute Hepatocellular Injury
Open to view video.
Open to view video.
Module 3 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 3 CE Evaluation
12 Questions
Module 3 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 3 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 3 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 3 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 4: Acute Cholestatic Liver Injury
Module 4 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 4: Acute Cholestatic Liver Injury
Open to view video.
Open to view video.
Module 4 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 4 CE Evaluation
12 Questions
Module 4 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 4 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 4 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 4 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 5: Chronic Hepatocellular Injury
Module 5 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 5: Chronic Hepatocellular Injury
Open to view video.
Open to view video.
Module 5 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 5 CE Evaluation
12 Questions
Module 5 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 5 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 5 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 5 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 6: Chronic Cholestatic Injury
Module 6 Pre-Test
6 Questions  |  1 attempt  |  0/6 points to pass
6 Questions  |  1 attempt  |  0/6 points to pass
Module 6: Chronic Cholestatic Injury
Open to view video.
Open to view video.
Module 6 Post-Test
6 Questions  |  Unlimited attempts  |  4/6 points to pass
6 Questions  |  Unlimited attempts  |  4/6 points to pass
Module 6 CE Evaluation
12 Questions
Module 6 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 6 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 6 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 6 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 7: Interpretation of Viral Serologies in Acute and Chronic Hepatitis
Module 7 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 7: Interpretation of Viral Serologies in Acute and Chronic Hepatitis
Open to view video.
Open to view video.
Module 7 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 7 CE Evaluation
12 Questions
Module 7 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 7 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 7 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 7 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 8: Outcomes of Patients with Abnormal Liver Tests
Module 8 Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
Module 8: Outcomes of Patients with Abnormal Liver Tests
Open to view video.
Open to view video.
Module 8 Post-Test
5 Questions  |  Unlimited attempts  |  3/5 points to pass
5 Questions  |  Unlimited attempts  |  3/5 points to pass
Module 8 CE Evaluation
12 Questions
Module 8 CE Credits
0.50 CE Credits credits  |  Certificate available
0.50 CE Credits credits  |  Certificate available
Module 8 CME Evaluation
7 Questions
7 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 8 CME Credits
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available
Module 8 MOC Points
Up to 0.50 medical credits available  |  Certificate available
Up to 0.50 medical credits available  |  Certificate available